Oxymatrine Shows Promise in Treating Alveolar Echinococcosis by Regulating Gut Microbiota

Fresh data on Parasitic Diseases and Conditions - Echinococcosis have been presented in a new report from Ningxia Medical University in Yinchuan, People's Republic of China. According to the research, alveolar echinococcosis (AE) is a zoonotic parasitic disease that poses a grave threat to human health, and recent studies have indicated that the gut microbiota plays a significant role in the pathogenesis of alveolar echinococcosis. The researchers found that oxymatrine, an alkaloid extracted from the legume plant Sophora flavescens, regulates gut microbiota and may be a viable treatment for alveolar echinococcosis.

Key Takeaways:

• Researchers at Ningxia Medical University discovered that oxymatrine, an alkaloid extracted from Sophora flavescens, significantly reduces the viability of Echinococcus multilocularis protoscoleces by inhibiting the growth of the parasite.
• Treatment with oxymatrine at concentrations of 0.35 mM, 0.5 mM, 0.75 mM, 1.0 mM, and 1.25 mM significantly reduced the viability of protoscoleces compared to the control group.
• The research found that oxymatrine alleviates Echinococcus multilocularis infection by remodeling the liver immune microenvironment and intestinal flora homeostasis.
• The 16S rRNA sequencing analysis revealed that OMT intervention enhanced the diversity of gut microbiota.
• Researchers concluded that matrine may play a therapeutic role in the early stage of alveolar echinococcosis, and OMT can exert an anti-infection effect in the middle and late stages of the disease.
• Oxymatrine was found to significantly increase the number of hepatic CD8 T cells and alleviate liver inflammatory cell infiltration and fibrosis.
• The research identified Peijiao Wu, Yazhou Zhu, Rou Wen, Jing Tang, Siyu Hou, Shiqin Yuan, Zihua Li, Ming Li, and Wei Zhao as the authors of the study.

Statistics:

• 0.35 mM, 0.5 mM, 0.75 mM, 1.0 mM, and 1.25 mM oxymatrine concentrations resulted in significant reduction of Echinococcus multilocularis protoscoleces viability.
• 25 mg/kg, 50 mg/kg, and 100 mg/kg oxymatrine doses showed significantly reduced cyst weights and alleviation of liver inflammatory cell infiltration and fibrosis.
• The 16S rRNA sequencing analysis revealed an increase in gut microbiota diversity after OMT intervention.

Sources:

• Oxymatrine alleviates Echinococcus multilocularis infection by remodeling the liver immune microenvironment and intestinal flora homeostasis. Frontiers in Cellular and Infection Microbiology, 2025;15:1658336.
• NewsRx. Researchers at Ningxia Medical University Target Echinococcosis (Oxymatrine alleviates Echinococcus multilocularis infection by remodeling the liver immune microenvironment and intestinal flora homeostasis). Life Science Weekly. November 4, 2025; p 5565.